Home/Filings/4/0001209191-10-051904
4//SEC Filing

HURWITZ EDWARD 4

Accession 0001209191-10-051904

CIK 0001338042other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 6:06 PM ET

Size

57.3 KB

Accession

0001209191-10-051904

Insider Transaction Report

Form 4
Period: 2010-10-27
CHAMPSI FARAH
10% Owner
Transactions
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
Transactions
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
Transactions
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
Transactions
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
Transactions
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
DELEAGE JEAN
10% Owner
Transactions
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+289,236$2,747,7422,455,167 total
  • Conversion

    Common Stock

    2010-10-27+25,49098,447 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+19,425$184,538164,882 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-2769,1760 total
    Common Stock (26,771 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2741,7680 total
    Common Stock (25,490 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (47,010 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+700,050$5,320,3802,165,931 total
  • Conversion

    Common Stock

    2010-10-27+72,95772,957 total
  • Purchase

    Common Stock

    2010-10-27$9.50/sh+7,128$67,71660,502 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-27188,5140 total
    Common Stock (72,957 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+47,010$357,276145,457 total
  • Conversion

    Common Stock

    2010-10-27+9,35336,124 total
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-27621,9230 total
    Common Stock (379,545 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2010-10-2715,3270 total
    Common Stock (9,353 underlying)
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (700,050 underlying)
  • Conversion

    Common Stock

    2010-10-27+1,086,3361,086,336 total
  • Conversion

    Common Stock

    2010-10-27+379,5451,465,881 total
  • Conversion

    Common Stock

    2010-10-27+26,77126,771 total
  • Conversion

    Series A Convertible Prefered Stock

    2010-10-272,806,9910 total
    Common Stock (1,086,336 underlying)
  • Conversion

    Common Stock

    2010-10-27$7.60/sh+17,250$131,10053,374 total
  • Conversion

    Senior Subordinated Convertible Promissory Notes

    2010-10-27
    Exercise: $7.60Exp: 2011-12-31Common Stock (17,250 underlying)
Footnotes (10)
  • [F1]Upon the closing of the Issuer's initial public offering on October 27, 2010, each share of Series A Convertible Preferred Stock (the "Series A Shares"), plus accrued dividends, automatically converted into shares of common stock of the Issuer in accordance with the terms of the Issuer's Third Amended and Restated Certificate of Incorporation. Each Series A Share converted into 0.38701117412 shares of common stock.
  • [F10]The Convertible Notes were issued on September 2, 2008, December 11, 2008, July 2, 2009, January 28, 2010, June 14, 2010, August 13, 2010 and October 1, 2010. Any outstanding principal amount and accrued but unpaid interest thereon was automatically convertible into shares of capital stock of the Issuer upon the consummation of specified sale transactions involving the securities of the Issuer, including an initial public offering of the Issuer's common stock meeting certain conditions.
  • [F2]Alta BioPharma Management III, LLC ("ABMIII") is the general partner of ABPIII and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). Jean Deleage, Farah Champsi, Edward Penhoet and Edward Hurwitz are the directors of ABMIII and managers of Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). Alison Kiley, a director of the Issuer, is a member of ABMIII and may be deemed to share investment power over the securities of the Issuer held by ABPIII, ABPIIIKG and AEBPIII with the directors of ABMIII and managers of AEBPIII. Each of Dr. Deleage, Ms. Champsi, Dr. Penhoet and Mr. Hurwitz disclaim beneficial ownership of such securities except to the extent of his or her pecuniary interest therein.
  • [F3]These securities are owned directly by ABPIII.
  • [F4]Upon the closing of the Issuer's initial public offering on October 27, 2010, each share of Series B Convertible Preferred Stock (the "Series B Shares"), plus accrued dividends, automatically converted into shares of common stock of the Issuer in accordance with the terms of the Issuer's Third Amended and Restated Certificate of Incorporation. Each Series B Share converted into 0.61027657931 basis of common stock.
  • [F5]The outstanding principal and accrued and unpaid interest on these Convertible Notes was automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering at $7.60 per share, which is equal to 80% of the Issuer's initial public offering price per share.
  • [F6]These securities are owned directly by ABPIIIKG.
  • [F7]These securities are owned directly by AEBPIII.
  • [F8]The Series A Shares were convertible at any time, at the holder's election, and automatically upon consummation of the Issuer's initial public offering and had no expiration date.
  • [F9]The Series B Shares were convertible at any time, at the holder's election, and automatically upon consummation of the Issuer's initial public offering and had no expiration date.

Issuer

Aegerion Pharmaceuticals, Inc.

CIK 0001338042

Entity typeother

Related Parties

1
  • filerCIK 0001211840

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 6:06 PM ET
Size
57.3 KB